Anthem Equity News
A “bionic man” showcased in a Smithsonian Channel documentary and exhibit was designed as an artificial human, though it lacks several working organs. But it has a beating heart — the Total Artificial Heart, made by Tucson-based SynCardia Systems Inc.
SynCardia Total Artificial Heart Provides Bridge to Transplant for 25-Year-Old Southern California Man Whose Father Died of the Same Disease.
Success is the achievement of something desired, planned or attempted. In this case, herding cows in less time than their competitors during three event rounds is what success looks like in this case. And that is exactly what Rodger Ford and his team accomplished at the 2013 Reno Rodeo
The Companion 2 (C2) Driver System is a CEO directed product championed by Rodger Ford during the time that he modernized the Total Artificial Heart.
Posted: Friday, June 14, 2013 12:00 am Entrepreneur Rodger Ford, who resuscitated artificial heart maker SynCardia and before that grew the printing firm Alphagraphics into a major force, has responded to prodding from friends and associates to write a book. Along with New York Times best-selling author Michael E. Gerber, Ford is co-authoring a book […]
Freedom® portable driver, the world’s first wearable power supply for the SynCardia temporary Total Artificial Heart, was named the 2013 Silver Winner amongst Assistive Devices in the Science/Medical category of the Edison Awards on April 25 in Chicago.
Rodger Ford has put together a winning formula for creating new business and watching it grow. New York Times best-selling author Michael E. Gerber is co-authoring a new book with Ford that will feature a behind the scenes look at what it takes to start a business from scratch and make it succeed.
Under Jameson’s leadership, the C2 was rapidly developed to be the state-of-the-art driver of the SynCardia Total Artificial Heart used by SynCardia Certified Centers.
The principle is to begin any enterprise with a solid system foundation or platform which allows ordinary people to become extraordinarily successful.
SynCardia announced today that the U.S. Food and Drug Administration (FDA) has approved two Humanitarian Use Device (HUD) designations for the new 50cc Total Artificial Heart to be used for destination therapy and pediatric bridge to transplant.